| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/16/2002 | US20020058607 Containing the amino acid sequence (G/S/A/E)-L-F-(F/I/L); each - is a peptide bond, each parenthesis encloses amino acids which are alternatives to one other, and each slash separating the alternative amino acids. |
| 05/16/2002 | US20020058336 Controlling cell binding; obtain target cell, incubate with substrate, monitor cell binding |
| 05/16/2002 | DE10054687A1 Inhibitoren von Transglutaminasen Inhibitors of transglutaminases |
| 05/16/2002 | CA2426030A1 Methods of treating disorders related to apoe |
| 05/15/2002 | EP1205487A1 Bicyclic dipeptide isosteres, their preparation and use as beta-turn mimics |
| 05/15/2002 | EP1204676A1 Streptogramin derivatives, preparation and compositions containing same |
| 05/15/2002 | EP1204411A1 Apicidin-derived cyclic tetrapeptides |
| 05/15/2002 | EP0837877B8 L-aspartyl-l-thienylalanine methyl esters, process for producing them and their use as sweeteners |
| 05/15/2002 | EP0729460B1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/15/2002 | CN1349542A Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 05/15/2002 | CN1349526A Prodrugs of thrombin inhibitors |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1084736C Substituted bheterocyclic carboxamide esters, their prepn. and their use as pharmaceuticals |
| 05/14/2002 | US6388132 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 05/14/2002 | US6388061 Includes ruthenium tris(bipyridyl) label bonded to the nitrogen base |
| 05/14/2002 | US6388054 Anti-cancer compounds |
| 05/14/2002 | US6387944 Benzo(b)thiepine-1,1-dioxide derivatives, a method for the production thereof, medicaments containing these compounds, and their use |
| 05/14/2002 | US6387924 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | US6387882 Vision defects; oxidation resistance; cosmetics; water solubility |
| 05/14/2002 | US6387881 Peptide |
| 05/14/2002 | CA2241210C Novel process for preparing n-acetyl(l)-4-cyanophenylalanine ac-(l)-phe(4-cn)-oh and n-acetyl-(l)-p-amidinophenylalanine-cyclohexylglycine-.beta.-(3-n-methylpyridinium)-alanine ac-(l)-paph-chg-palme(3)-nh2 |
| 05/10/2002 | WO2002036798A2 Inhibitors of transglutaminases |
| 05/10/2002 | WO2002036551A1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 05/10/2002 | WO2002036173A2 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 05/10/2002 | WO2002009641A3 Promyostatin peptides and methods of using same |
| 05/10/2002 | WO2001089282A3 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives |
| 05/10/2002 | WO2001087927A3 gYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER USING L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER PRECURSORS |
| 05/10/2002 | WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/10/2002 | CA2427911A1 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/09/2002 | US20020055466 Terpolymer of tyrosine, alanine and lysine randomly polymerized into a polypeptide |
| 05/09/2002 | US20020055463 Peptidomimetics for Grb2 (growth factor receptor binding protein); treating cancer, metastasis and proliferative disorders |
| 05/08/2002 | EP1203026A1 Binding moieties for fibrin |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1043322B1 Vitamin e derivatives |
| 05/08/2002 | EP0914332B1 Isoquinolines useful as analgesics |
| 05/08/2002 | EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 05/08/2002 | EP0723545B1 Quinolizinone type compounds |
| 05/07/2002 | US6384272 Formation of ammonium salt of (alpha-aspartyl)phenylalanine by amidation of ester of (alpha-aspartyl)phenylalanine, then (alpha-aspartyl)-beta-cyclohexylalaninamide is obtained by catalytic hydrogenation |
| 05/07/2002 | US6384218 Prepared by reacting amino acid, oligo- or polypeptide or polyamino acid with trialdehyde; molecular recognition agent for use in neurotransmission studies |
| 05/07/2002 | US6384189 Compositions for stimulating TGF-β activity |
| 05/07/2002 | US6384076 Inhibition or erythrocyte sickling by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester |
| 05/07/2002 | US6384065 Spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and AP-1 inhibitors containing the same |
| 05/07/2002 | US6384014 Antibiotics as bactericides |
| 05/02/2002 | WO2002034915A2 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | WO2002034767A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | WO2002034765A2 us0130034IDIC TRYPTASE SUBSTRATES AND ASSAY FOR TRYPTASE ACTIVITY USING SAME |
| 05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | WO2001097217A3 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 05/02/2002 | WO2001090745A3 Determination of naaladase inhibitors |
| 05/02/2002 | WO2001083770A3 Lipolytic enzyme variant |
| 05/02/2002 | WO2001058957A3 Enhancing the circulating half-life of antibody-based fusion proteins |
| 05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | US20020052422 Oral drug delivery compositions and methods |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052354 Paramagnetic DOTA derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction |
| 05/02/2002 | US20020052323 Protease inhibitors, particularly for caspase enzyme; treating arthritis, ALS, MS, and the like. |
| 05/02/2002 | US20020052322 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 05/02/2002 | US20020052321 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/02/2002 | US20020052007 Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
| 05/02/2002 | US20020051988 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 05/02/2002 | EP1200457A2 Cysteine protease inhibitors |
| 05/02/2002 | EP0746567B1 Novel opioid peptides for the treatment of pain and use thereof |
| 05/02/2002 | CA2427070A1 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/01/2002 | CN1347420A Growth hormone secretagogues |
| 05/01/2002 | CN1347419A Pyrrolidincarbonylamino cyclic disulfides |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 04/30/2002 | US6380387 Antiinflammatory agents, antiasthmatics |
| 04/30/2002 | US6380262 5-membered ring compounds |
| 04/30/2002 | US6380215 For prevention and/or treatment of diseases caused by thrombus formation such as arterial thrombosis, arterial sclerosis, ischemic heart diseases |
| 04/30/2002 | US6380156 Having antiviral, antitumor, and immunosuppressive activities |
| 04/30/2002 | US6379954 Amido and peptido modified catalytic oligonucleotides |
| 04/30/2002 | CA2170872C Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process |
| 04/30/2002 | CA2054111C Novel inhibitory peptides |
| 04/25/2002 | WO2002032888A1 Substituted dipeptides as growth hormone secretagogues |
| 04/25/2002 | WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032376A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 04/25/2002 | WO2002032291A2 Imaging of enzymatic activity |
| 04/25/2002 | WO2001096366A3 Dipeptide inhibitors for the blood-clotting factor xa |
| 04/25/2002 | WO2001060848A3 Conjugates targeted to target receptors |
| 04/25/2002 | US20020049316 Protease inhibitors |
| 04/25/2002 | US20020049303 Enzymatic polypeptide for use as model for treatment of alzheimer's disease |
| 04/25/2002 | US20020049196 Hexahydro-pyrazolo-(4,3-c)pyridine derivatives useful for increasing the endogenous production or release of growth hormone in a human or other animal, thus treat or prevent osteoporosis |
| 04/25/2002 | US20020049190 Useful in binding nitric oxide; inhibiting tumor growth |
| 04/25/2002 | US20020049185 Malonic acid based matrix metalloproteinase inhibitors |
| 04/25/2002 | US20020049164 Prodrugs of DP IV-inhibitors |
| 04/25/2002 | US20020049162 Methods for inhibiting smooth muscle cell proliferation |
| 04/25/2002 | US20020049153 Modified peptides capable of forming covalent bonds with one or more blood components, especially albumin, to form a conjugate; administered to treat humans with diabetes |
| 04/25/2002 | DE10050091A1 New casein-derived peptide with growth promoting activity, useful as additive for eukaryotic cell cultures and for recombinant protein production |
| 04/25/2002 | CA2425873A1 Imaging of enzymatic activity |